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Some recent explanations of depression have suggested that it may be “evolutionary” in that there are advantages to the depressed
individual which arise from some aspects of depressive symptomatology. While the depressive behaviour of withdrawal from the
adverseenvironmentmayprovidesomeimmediatebeneﬁtstothedepressedindividual,thusmakingitpotentially“adaptive”inthe
short-term, this does not ﬁt the biological deﬁnition of “evolutionary”. In fact, depression does not meet two of the three required
criteria from natural selection in order to be evolutionary. Therefore, while some depressive behaviour may be advantageous for
the depressed individual, and is therefore “adaptive” in an immediate sense, it cannot be accurately described as “evolutionary”.
Implications for research and clinical practice are discussed.
1. Genes,Behaviour andDepression
Clinical and subsyndromal depression adversely aﬀect phys-
ical health, relationships, and cognitive performance [1–4].
With between 13% (Europe) and 17% (USA) of people
having a major depressive episode at some time in their
lives [5–7], depression has been described as the major
contributor to the total disease burden [8] and predicted
to become the second leading cause of mental illness by
2020 [9, 10]. As an indicator of its eﬀect upon health,
depression has recently been shown to have almost the same
predictive power for mortality as does smoking [11]. One of
the strongest predictors of depression is stress in the form
of demanding challenges across a range of areas [12], acting
through a variety of causal pathways including genetic and
behavioural factors which may undermine an individual’s
ability to withstand stress [13, 14].
Although genetic linkage studies in depression have not
previously been as successful as those for other disorders
such as schizophrenia [15], there are some recent ﬁnd-
ings regarding the genetic basis of depression which have
suggested speciﬁc genes which may, when combined with
perceived uncontrollable environmental challenges, have
statistically signiﬁcant relationships with major depressive
disorder (MDD). For example, Wang et al. [16] identiﬁed
four genes that activate the secretion of corticotrophin-
releasing hormone (CRH) from the hypothalamus and that
show signiﬁcantly higher expression in depressed than in
nondepressed persons. CRH and its downstream consequent
cortisol are consistently elevated in depressed patients [17–
20], and these elevations have been associated with neuronal
apoptosis in the hippocampus and prefrontal cortex and
increased neurogenesis within the amygdala, leading to what
Arnsten [21] referred to as a change from cognitive-based
“top down” to emotion-based “bottom up” decision-making
during chronic stress, which is a characteristic of depressed
persons. Other genetic links with depression have been
reported through polymorphisms and allele dominance on
the serotonin transporter gene 5-HTT,[ 22], the piccolo
gene PCLO, which inﬂuences monoaminergic neurotrans-
mitters in the brain [23], and gene-linked malfunctions
of the glutamate and GABA systems [24], which reduce
the functionality of the neurotransmitters serotonin [25]
and dopamine [26], thus impairing cognitive performance,
one of the symptoms of depression [27] .Ar e c e n tm e t a -
analysis of 193 research reports on 393 genetic polymor-
phisms identiﬁed six “MDD susceptibility genes” [14,p a g e
772] that showed statistically signiﬁcant relationships with2 Depression Research and Treatment
MDD. Perhaps highlighting the “active” role of the gene-
environmental interaction hypothesis of depression [28],
Belsky et al., [29] has suggested that instead of considering
some genes as representing a vulnerability to depression,
they might more accurately be described as “plasticity genes”
(page 746) because they predispose some individuals to
depressive responses to environmental stressors.
Following from the initial genetic predisposition or
vulnerability to depression, behaviours that have been
associated with depression include negative self-evaluation,
depressive attributional style, distorted cognitive process-
ing, deﬁciencies in social skills, avoidance behaviours [30]
and ineﬀective problem-solving [31], some of which may
contribute to the depressed person’s perception that a
particular environmental stressor is uncontrollable. While
these factors exist in their own right as research-based
predictors of depression, they more accurately should be
seen as the “behavioural pathways” through which an
individual may respond to a major environmental stres-
sor. As will be described in detail below, those pathways
can be subsumed under the general descriptor of “active
withdrawal” from stressors that are perceived as inescapable
and uncontrollable [32]. These behavioural factors may be
more likely to occur as a result of genetic predisposition,
but they usually require the learning of behaviour patterns
from previous experience to become entrenched within an
individual’s behavioural repertoire. That is, individuals will
respond to stressors according to their combined genetic and
behavioural characteristics. Those responses may perhaps
be inﬂuenced diﬀerentially (i.e., reinforced or extinguished)
over time and circumstances by these characteristics and the
relevant impact which a particular stressor has upon the
individual. Evidence of variability in individuals’ depression
symptoms over time and/or depressive episodes points to
such diﬀerential responsivity to stressors and supports the
construct of an individual stressor-depressive symptoms
interaction model [33].
2. Evolutionaryor Adaptive?
2.1. Evolutionary. To explain the presence of those genetic-
based factors which predispose certain individuals to depres-
sion, several papers have hypothesised an “evolutionary”
model of depression which focuses upon the apparent
beneﬁt that emitting depressive behaviours in response to
stressors has for the depressed individual (e.g., [34–41]).
That literature suggests that depression has evolved to
perform two problem-solving functions: (1) to withdraw
from the stressor and so allow the depressed individual time
to analyse the stressful situation they ﬁnd themselves in, and
(2) to elicit assistance from partners and close others [42].
However, this model is not without its critics (e.g., [43, 44])
and may also be misnamed on biological grounds.
That is, from a biological perspective, for a trait (such as
a predisposition to depressive behaviour) to be considered
as “evolutionary”, it must fulﬁl several criteria. Following
Darwin’s [45] postulates and more recent developments [46,
47],diﬀerenttraitsnaturallyexistbetweenindividualswithin
a population, and if those diﬀerent traits are passed on to
oﬀspring and confer a survival or reproductive advantage
to those oﬀspring, the traits will be naturally selected and
will become more common. When this happens, it may
be said that evolutionary processes are at work [48]. That
is, as a series of steps: (1) the trait in question must
be present in one generation and passed on to the next
generation via genetic inheritance; (2) the attribute that is
passed on must confer some “selective ﬁtness” beneﬁt to the
oﬀspring of the parent with the trait [49, 50]). That is, the
trait must pass from the parent to the oﬀspring and must
enhance the second generation’s chances of reproducing
successfully (deﬁned as bringing their own oﬀspring to
reproduction age) [47, 51]. Of particular importance to
the current discussion, the trait cannot be developed (e.g.,
in response to environmental stressors) during the parent’s
lifetime (that would be Lamarckism, not “evolutionary” in
the current Darwinian sense). Following this model, to be an
evolutionary-based behaviour, depression in parents would
(a) somehow enhance their chances of reproducing success-
fully,(b)bepassedontotheirchildren,and(c)enhancetheir
children’s chances of also reproducing successfully. As will be
explained below, only one of these three requirements is met
by depression.
Taking the ﬁrst of these requirements (i.e., being
depressed conveys some kind of survival and/or repro-
ductive beneﬁt to the depressed person), although being
depressed may have some immediate beneﬁcial outcome for
the depressed person (i.e., withdrawal from uncontrollable
aversive environmental stressors, enlisting others’ help in
dealing with those stressors), it is diﬃcult to immediately see
how being depressed conveys an advantage to the depressed
person in an evolutionary (i.e., reproductive ﬁtness) sense.
In order to meet this criteria, the evolutionary hypothesis
would have to show that simply being depressed helped
depressed individuals to obtain an advantage in reproducing
themselves and bringing their own oﬀspring to reproductive
maturity.Tothecontrary,dataregardingthecareersuccessof
people with depression indicate that they are less productive
at work [52] and earn between 13% and 18% less than
their nondepressed colleagues [53], thus providing them
with less of the income which may be used to provide for
a family and for their own health and well-being. Further,
20% of depressed employees report complete or occasional
inability to carry out work responsibilities, 83% say they
lack motivation, and 82% report diﬃculties concentrating
[54], further reducing their value to employers and thence
their earning capacity. Depression may also prevent patients
from earning at all, with 34% of unemployed people in
the UK being excluded from work by depression [55]. In
addition, being depressed increases the likelihood of suicide
[56]. These are not the likely hallmarks of individuals who
will produce successful oﬀspring, at least within recorded
history. Nor are the underlying behaviour patterns of these
people likely to have been beneﬁcial to their archeological
ancestors,consisting astheydooflow motivation tosucceed,
inability to perform tasks when under demand, and lack of
thekindsofbehaviourswhichleadtomaterialwealth,health,
and well-being. Even if being depressed interacted with aDepression Research and Treatment 3
particular environmental situation and thereby provided a
hypothetical advantage for the depressed person within such
an environment, such an advantage has not been reported
in the wider literature to date, apart from being diﬃcult
to envisage. In fact, and as mentioned above, depression’s
parallel risk status with smoking as a predictor of mortality
(even when related health factors such as blood pressure,
alcohol intake, cholesterol and social status are taken into
account) argues against there being any demonstrated
survival value for depression [11]. Thus, the likelihood of
depression holding any (previously hidden) compensatory
eﬀects on survival remains to be demonstrated, at best.
The second requirement of an evolutionary trait (i.e., the
depressed characteristic is passed on to oﬀspring genetically)
is met in that family studies of depression reliably produce
a ﬁgure of 80% heritability [57, 58] for bipolar disorder,
with some data identifying speciﬁc alleles that are respon-
sible for parent-child transmission [59]. Similar data have
been reported for parent-child links for Major Depressive
Disorder (MDD), with children whose both parents had
MDD having a 74% chance of developing the same disorder
and children with one parent with MDD having a 27%
chance of becoming severely depressed compared to 7% for
children with neither parent meeting the criteria for MDD
[60]. Other studies (e.g., [61, 62]) reported similar results,
suggesting that having parents who suﬀered from depression
was a strong indicator of elevated risk of oﬀspring also
developing depression. In addition to the genetic linkage
studies reported earlier in this paper, these data support
the presence of a genetic inheritance causal variable in
transmission of depression; children of depressed parents are
also more likely to be depressed themselves than children of
nondepressed parents.
Third (i.e., being the child of depressed parents enhances
a child’s own survival and reproductive success), there
are multiple studies which have reported that children of
depressed parents react more negatively to stressors, are
delayed in their acquisition of self-regulation strategies, have
more school problems, higher levels of behaviour problems
and lower self-esteem (for reviews, see, [63–65]). Even
though the construct of antagonistic pleiotropy (i.e., that
a gene may transmit beneﬁcial as well as damaging traits:
[66]) might be raised as a possible way in which depression
holds an evolutionary advantage for the later oﬀspring of
depressed parents (i.e., that the beneﬁt might not emerge
in the ﬁrst generation of the depressed parents’ oﬀspring
but may be apparent in later generations), there are no data
extant in the literature which support this hypothesis. To the
contrary, as well as the presence of disorders in children of
depressed parents including anxiety [67], many adjustment
problems (mentioned above) at school and later at work
[68], substance abuse [69], and relationship diﬃculties
[70], the incidence of those disorders among children is
very large. For example, parental MDD is associated with
an eightfold increased risk of MDD in their children, a
threefold increased risk of anxiety disorders, and a ﬁvefold
increased risk of conduct disorder [71]. In addition, the
presence of these problems has been noted in grandchildren
of depressed parents [72], arguing against the antagonistic
pleiotropy hypothesis in this case. Further, in a study of the
eﬀects of pleiotropy in the genes responsible for depression,
Gorwood [73] reported that the strongest genetic link with
MDD was generalized anxiety disorder. While there may
be some epigenetic inﬂuences present in these behaviours
that inculcate parental behaviour in the development of
children’s predisposition to depression [74, 75], the surmise
that these children are likely to succeed at school, become
career successful, and amass the large resources that are
characteristics of individuals whose oﬀspring have the
greatest chance of reproducing themselves and managing
their lives eﬀectively (i.e., show reproductive ﬁtness) is not
supportedbyfact[61].Again, thekinds ofbehavioursshown
by children of depressed parents and listed above would not
be likely to confer a reproductive advantage for the ancestors
of H. sapiens.
2.2. Adaptive. However, the “evolutionary” argument might
be modiﬁed to explain one set of immediate beneﬁts of
depressive behaviour to those individuals who suﬀer from
the disorder without necessary reference to the reproductive
success of their oﬀspring. That is, by reference to the
argument underlying the “evolutionary” hypothesis that
being depressed provides an adaptive advantage for the
individual in the current environment.A sm e n t i o n e db r i e ﬂ y
above, one theory of depression which is based upon the
assumption that depressive behaviour bestows some beneﬁt
upon the person exhibiting it has been described by several
authors (e.g., [76–78]). As noted by Bolling et al. [32],
“Identiﬁed features of the depressive syndrome are all in
the spectrum of a withdrawal from contact with the world
and the consequences of activity” (page 127). Applied to the
speciﬁc symptomatology of depression, sadness, anhedonia,
sleep and appetite change and cognitive disturbances are
part of a “biological response pattern ... identiﬁed as the
conservation-withdrawal response to excesses or deﬁcits of
stimulation” (page 127) that includes low self-esteem, hope-
lessness, and helplessness. This withdrawal from aversive
stimuli and environments has been described as “adaptive”
in that it reduces the quantum of noxious stimuli to which
the person is exposed [35, 36]. An important aspect of the
mechanism underlying this withdrawal is the conviction on
the part of the depressive person that he/she has no real
control over the unpleasant experience that is occurring
[35, 36] and therefore is left with a single response that will
reduce distress—withdrawal from the environment that is
causing the unpleasantness.
This immediate beneﬁt from depression is what Darwin
1876/2002 ([79,p a g e5 1 ] )r e f e r r e dt ow h e nh ec o m m e n t e d
t h a t“ B u tp a i no rs u ﬀering of any kind, if long continued,
causes depression and lessens the power of action; yet it
is well adapted to make a creature guard itself against any
great or sudden evil”. That is, while depression may provide
an advantage of some degree to the suﬀerer, that advantage
may not be of major beneﬁt and certainly does not enhance
the likelihood of reproducing successfully. In addition,
maintenance of depressive withdrawal behaviour means that
the depressed individual also loses access to available sources4 Depression Research and Treatment
of social reinforcement, potentially setting up a circular
process in which withdrawal from an aversive environment
becomes both self-reinforcing and self-defeating [78]. As
such, while depressive responses to unmanageable stressors
may be initially “adaptive”, they probably are not so in the
longer term. Furthermore, depressive withdrawal does not
need to be “evolutionary” (i.e., transgenerational) in order
to be conceptualized as conveying some immediate beneﬁt
to the depressed individual. That is, depressive may simply
be “adaptive” in the short term. This leaves the investigation
of depression open to consideration of the immediate
“adaptive” beneﬁts of depressive-withdrawal responses to
unmanageable stressors.
3. Implications for Research
Because depressive withdrawal may convey some short-
term advantages to the depressed individual, investigation
of these advantages, and the environmental stressors which
cause the individual to withdraw, presents a potentially
fruitful area of research. If it is assumed that (according to
the adaptation model of depressive withdrawal behaviour
described above) the major advantage which proceeds from
withdrawal is the relative absence of the stressor, then it
becomes even more relevant to investigate the kinds of
stressors which the depressed individual seeks to escape from
when they withdraw. In their examination of the kinds of
stressors that were associated with depression, Keller and
Nesse [80] investigated the match between categories of
stressors which they termed “precipitants” (page 27) and the
presence of six subgroups of depressive symptoms assessed
via the Centre for Epidemiological Studies Depression Scale.
Diﬀerent stressors were associated with diﬀerent depressive
symptoms: for example, social losses were associated with
cryingandarousal,andfailuretoreachagoalwaslinkedwith
fatigue and pessimism. These ﬁndings were replicated [81]
and extended to include nine sets of stressors [82]. However,
the focus of those investigations was upon categories of
stressors (such as death of a loved one, failure, romantic loss,
inability to cope, social isolation and winter), and it may also
be fruitful to investigate the speciﬁc events which individuals
ﬁnd suﬃciently stressful to initiate withdrawal behaviour
(andwhich,thereby,conveysomeadvantagetothedepressed
individual). As has been shown previously, not all assumed
stressors have negative eﬀects upon those who experience
them,andsomeevenhavereportedlypositiveeﬀects[83,84],
thus challenging the validity of grouping many stressors into
categories.
4. ClinicalDirections
The focusing of research investigations onto the stressors
whichprecipitatedepressivewithdrawalthusappearstomost
likelybeofbeneﬁtifitisperformedfromanideographicper-
spective rather than a nomothetic one. That is, identiﬁcation
of groups or categories of stressors may be valuable as a ﬁrst
step in this process, but clinical treatment models that are
based upon an adaptive model of depression require more
precise identiﬁcation of those speciﬁc stressors which initiate
depressive withdrawal behaviour in a particular patient. One
model which proceeds on this basis is Functional Analysis
of depression Kanter et al., [85]; Kohlenberg et al., [86]. This
approachiswellsuitedtoclinicalinvestigationsofdepression
from an adaptive perspective because it assumes that the
depressive behaviour itself is reinforced by its consequences,
thus readily identifying the speciﬁc stressors, the depressive
behaviour, and the advantages which ﬂow to the depressed
individual from their depressive (withdrawal) behaviour.
5. Conclusion
Initially, depression appears to confer such misery upon the
suﬀerer that it may be diﬃcult to imagine that it also has
advantages for that person. However, like other physiological
functions which cause discomfort (such as raised temper-
ature and inﬂammation) depressive withdrawal behaviour
may also have a functional aspect. As noted by Moskowitz
[87], even the apparently bizarre behaviour of catatonia can
have self-protective beneﬁts for the organism (i.e., stillness
in the face of unavoidable threat from predators can assist in
evading death), and depressive withdrawal may also convey
a similar beneﬁt to the depressed person. While it cannot be
classiﬁed as evolutionary because of the reasons given above,
withdrawal from uncontrollable danger or pain is, from all
perspectives, advantageous for the person who exhibits such
behaviour and therefore may be seen as adaptive.
Acknowledgment
The author is grateful to Glenda Vaughton for her helpful
comments on a previous draft of this ms.
References
[1] B.G. Drussand R.A.Rosenheck, “Patternsofhealth carecosts
associated with depression and substance abuse in a national
sample,” Psychiatric Services, vol. 50, no. 2, pp. 214–218, 1999.
[2] L. L. Judd, M. P. Paulus, K. B. Wells, and M. H. Rapa-
port, “Socioeconomic burden of subsyndromal depressive
symptoms and major depression in a sample of the general
population,” American Journal of Psychiatry, vol. 153, no. 11,
pp. 1411–1417, 1996.
[3] J. M. Lyness, M. Heo, C. J. Datto, et al., “Outcomes of
minor and subsyndromal depression among elderly patients
in primary care settings,” Annals of Internal Medicine, vol. 144,
no. 7, pp. 496–504, 2006.
[4] D. Nutt, “Anxiety and depression: individual entities or two
sides of the same coin?” International Journal of Psychiatry in
Clinical Practice, vol. 8, supplement 1, pp. 19–24, 2004.
[ 5 ]J .A l o n s o ,M .C .A n g e r m e y e r ,S .B e r n e r t ,e ta l . ,“ P r e v a l e n c eo f
mental disorders in Europe: results from the European Study
of the Epidemiology of Mental Disorders (ESEMeD) project,”
Acta Psychiatrica Scandinavica, vol. 109, supplement 420, pp.
21–27, 2004.
[6] R. C. Kessler, K. A. McGonagle, S. Zhao, et al., “Lifetime
and 12-month prevalence of DSM-III-R psychiatric disorders
in the United States: results from the National ComorbidityDepression Research and Treatment 5
Survey,” Archives of General Psychiatry, vol. 51, no. 1, pp. 8–19,
1994.
[7] R. C. Kessler, P. Berglund, G. Borges, M. Nock, and P. S. Wang,
“Trends in suicide ideation, plans, gestures, and attempts in
the United States, 1990–1992 to 2001–2003,” Journal of the
American Medical Association, vol. 293, no. 20, pp. 2487–2495,
2005.
[8] T. B. Ustun, J. L. Ayuso-Mateos, S. Chatterji, C. Mathers, and
C. J. L. Murray, “Global burden of depressive disorders in the
year 2000,” British Journal of Psychiatry, vol. 184, pp. 386–392,
2004.
[9] C. J. L. Murray and A. D. Lopez, “Alternative projections of
mortality and disability by cause 1990–2020: global burden of
disease study,” The Lancet, vol. 349, no. 9064, pp. 1498–1504,
1997.
[10] L. Andrade, J. J. Caraveo-Anduaga, P. Berglund, et al., “Cross-
national comparisons of the prevalences and correlates of
mental disorders,” Bulletin of the World Health Organization,
vol. 78, no. 4, pp. 413–426, 2000.
[11] A. Mykletun, O. Bjerkeset, S. ∅verland, M. Prince, M. Dewey,
and R. Stewart, “Levels of anxiety and depression as predictors
of mortality: the HUNT study,” British Journal of Psychiatry,
vol. 195, no. 2, pp. 118–125, 2009.
[12] C. Mirescu and E. Gould, “Stress and adult neurogenesis,”
Hippocampus, vol. 16, no. 3, pp. 233–238, 2006.
[13] J. M. Hettema, S. S. An, M. C. Neale, et al., “Association
between glutamic acid decarboxylase genes and anxiety
disorders, major depression, and neuroticism,” Molecular
Psychiatry, vol. 11, no. 8, pp. 752–762, 2006.
[14] S. L´ opez-Le´ o n ,A .C .J .W .J a n s s e n s ,A .M .G o n z ´ alez-Zuloeta
Ladd, et al., “Meta-analyses of genetic studies on major
depressive disorder,” Molecular Psychiatry,v o l .1 3 ,n o .8 ,p p .
772–785, 2008.
[15] P. McGuﬃn, S. Cohen, and J. Knight, “Homing in on
depression genes,” AmericanJournalofPsychiatry,vol.164,no.
2, pp. 195–197, 2007.
[16] S.-S. Wang, W. Kamphuis, I. Huitinga, J.-N. Zhou, and D. F.
Swaab, “Gene expression analysis in the human hypothalamus
in depression by laser microdissection and real-time PCR:
the presence of multiple receptor imbalances,” Molecular
Psychiatry, vol. 13, no. 8, pp. 786–799, 2008.
[17] B. J. Carroll, J. F. Greden, M. Feinberg, et al., “Neuroendocrine
evaluation of depression in borderline patients,” Psychiatric
Clinics of North America, vol. 4, no. 1, pp. 89–99, 1981.
[18] C. F. Gillespie and C. B. Nemeroﬀ, “Hypercortisolemia and
depression,” Psychosomatic Medicine, vol. 67, supplement 1,
pp. S26–S28, 2005.
[19] F. Holsboer, “Corticotropin-releasing hormone modulators
and depression,” Current Opinion in Investigational Drugs, vol.
4, no. 1, pp. 46–50, 2003.
[20] P. M. Plotsky, M. J. Owens, and C. B. Nemeroﬀ,
“Psychoneuroendocrinology of depression: hypothalamic-
pituitary-adrenal axis,” Psychiatric Clinics of North America,
vol. 21, no. 2, pp. 293–307, 1998.
[21] A. F. T. Arnsten, “Stress signalling pathways that impair
prefrontal cortex structure and function,” Nature Reviews
Neuroscience, vol. 10, no. 6, pp. 410–422, 2009.
[22] R. Uher and P. McGuﬃn, “The moderation by the serotonin
transportergeneofenvironmentaladversityintheaetiologyof
mental illness: review and methodological analysis,” Molecular
Psychiatry, vol. 13, no. 2, pp. 131–146, 2008.
[23] P. F. Sullivan, E. J. C. De Geus, G. Willemsen, et al., “Genome-
wide association for major depressive disorder: a possible role
for the presynaptic protein piccolo,” Molecular Psychiatry, vol.
14, no. 4, pp. 359–375, 2009.
[24] G. Sanacora, G. F. Mason, and J. H. Krystal, “Impairment
of GABAergic transmission in depression: new insights from
neuroimaging studies,” Critical Reviews in Neurobiology, vol.
14, no. 1, pp. 23–45, 2000.
[25] N. M¨ uller and M. J. Schwarz, “The immune-mediated alter-
ation of serotonin and glutamate: towards an integrated view
of depression,” Molecular Psychiatry, vol. 12, no. 11, pp. 988–
1000, 2007.
[ 2 6 ]P .V .C h o u d a r y ,M .M o l n a r ,S .J .E v a n s ,e ta l . ,“ A l t e r e d
cortical glutamatergic and GABAergic signal transmission
with glial involvement in depression,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 102, no. 43, pp. 15653–15658, 2005.
[27] American Psychiatric Association, Diagnostic and Statistical
Manual of Mental Disorders. Ed. 4-Text Revision, American
Psychiatric Association, Washington, DC, USA, 2000.
[28] R. Uher, “The implications of gene-environment interactions
in depression: will cause inform cure?” Molecular Psychiatry,
vol. 13, no. 12, pp. 1070–1078, 2008.
[29] J. Belsky, C. Jonassaint, M. Pluess, M. Stanton, B. Brummett,
and R. Williams, “Vulnerability genes or plasticity genes?”
Molecular Psychiatry, vol. 14, no. 8, pp. 746–754, 2009.
[30] D. R. Hopko, S. D. Hopko, and C. W. Lejuez, “Mood
disorders,”inTheHandbookofFunctionalAnalysisandClinical
Psychology, P. Sturmey, Ed., pp. 307–334, Elsevier Press, New
York, NY, USA, 2007.
[31] A.M.Nezu,“Problemsolvingandbehaviortherapyrevisited,”
Behavior Therapy, vol. 35, no. 1, pp. 1–33, 2004.
[32] M. Y. Bolling, R. J. Kolenberg, and C. R. Parker, “Behavior
analysis and depression,” in Clinical Behaviour Analysis,M .J .
Dougher, Ed., pp. 127–153, Context Press, Reno, Nev, USA,
1999.
[33] M. A. Oquendo, A. Barrera, S. P. Ellis, et al., “Instability of
symptomsinrecurrentmajordepression:aprospectivestudy,”
American Journal of Psychiatry, vol. 161, no. 2, pp. 255–261,
2004.
[34] N. B. Allen and P. B. T. Badcock, “Darwinian models of
depression: a review of evolutionary accounts of mood and
mood disorders,” Progress in Neuro-Psychopharmacology and
Biological Psychiatry, vol. 30, no. 5, pp. 815–826, 2006.
[35] P. Gilbert, “The evolved basis and adaptive functions of
cognitive distortions,” British Journal of Medical Psychology,
vol. 71, no. 4, pp. 447–463, 1998.
[36] P. Gilbert, “Evolution and depression: issues and implica-
tions,” Psychological Medicine, vol. 36, no. 3, pp. 287–297,
2006.
[37] M. C. Keller, “The evolutionary persistence of genes that
increase mental disorders risk,” Current Directions in Psycho-
logical Science, vol. 17, no. 6, pp. 395–399, 2008.
[38] R. Nesse, “Emotional disorders in evolutionary perspective,”
British Journal of Medical Psychology, vol. 71, no. 4, pp. 397–
415, 1998.
[39] R.M.Nesse,“Isdepressionanadaptation?”Archives of General
Psychiatry, vol. 57, no. 1, pp. 14–20, 2000.
[40] D.Nettle,“Anevolutionarymodeloflowmoodstates,”Journal
of Theoretical Biology, vol. 257, no. 1, pp. 100–103, 2009.
[41] J. Price, “The adaptive function of mood change,” British
JournalofMedicalPsychology,vol.71,no.4,pp.465–477,1998.6 Depression Research and Treatment
[ 4 2 ]P .J .W a t s o na n dP .W .A n d r e w s ,“ T o w a r dar e v i s e de v o l u t i o n -
ary adaptationist analysis of depression: the social navigation
hypothesis,” Journal of Aﬀective Disorders,v o l .7 2 ,n o .1 ,p p .
1–14, 2002.
[43] J. K. Burns, “Reconciling ‘the new epidemiology’ with an evo-
lutionary genetic basis for schizophrenia,” Medical Hypotheses,
vol. 72, no. 3, pp. 353–358, 2009.
[44] C. A. Hendrie and A. R. Pickles, “Depression as an evolution-
aryadaptation:implicationsforthedevelopmentofpreclinical
models,” Medical Hypotheses, vol. 72, no. 3, pp. 342–347, 2009.
[45] C. Darwin, T h eO r i g i no fS p e c i e sb yN a t u r a lS e l e c t i o n ,J o h n
Murray, London, UK, 1859.
[46] T. Dobzhansky, F. G. Ayala, G. L. Stebbins, and J. W. Valentine,
Evolution, W.H. Freeman, SanFrancisco, Calif, USA, 1977.
[47] J. A. de Visser, J. Hermisson, G. P. Wagner, et al., “Perspective:
evolution and detection of genetic robustness,” Evolution, vol.
57, no. 9, pp. 1959–1972, 2003.
[48] G. Bell, Selection: The Mechanism of Evolution, Chapman &
Hall, New York, NY, USA, 1997.
[49] R. C. Lewontin, “The units of selection,” Annual Review of
Ecology & Systematics, vol. 1, no. 1, pp. 1–18, 1970.
[50] E. Mayr, Systematics and the Origin of Species, Columbia
University Press, New York, NY, USA, 1942.
[51] S. Freeman and J. C. Herron, Evolutionary Analysis, Pearson
Prentice Hall, Upper Saddle River, NJ, USA, 2007.
[52] W. F. Stewart, J. A. Ricci, E. Chee, S. R. Hahn, and D.
Morganstein, “Cost of lost productive work time among US
workers with depression,” Journal of the American Medical
Association, vol. 289, no. 23, pp. 3135–3144, 2003.
[ 5 3 ]S .L .E t t n e r ,R .G .F r a n k ,a n dR .C .K e s s l e r ,“ T h ei m p a c to f
psychiatric disorders on labor market outcomes,” Industrial
and Labor Relations Review, vol. 51, no. 1, pp. 64–81, 1997.
[54] University of Michigan Depression Centre and National
Mental Health Association, “Is depression a roadblock to
career success?” Media Symposium, March 2004.
[55] P. A. Kemp and J. Davidson, “Routes onto incapacity beneﬁt:
ﬁndings from a survey of recent claimants,” Research Report
469, Department of Work and Pensions, Norwich, UK, 2007.
[56] G. W. Blair-West, C. H. Cantor, G. W. Mellsop, and M. L.
Eyeson-Annan, “Lifetime suicide risk in major depression: sex
and age determinants,” Journal of Aﬀective Disorders, vol. 55,
no. 2-3, pp. 171–178, 1999.
[57] W. Berrettini, “Genetic of bipolar and unipolar disorders,”
in Textbook of Mood Disorders, D. J. Stein, D. J. Kupfer, and
A. F. Schatzberg, Eds., pp. 235–247, American Psychiatric
Association, Washington, DC, USA, 2006.
[58] P. McGuﬃn, F. Rijsdijk, M. Andrew, P. Sham, R. Katz, and
A. Cardno, “The heritability of bipolar aﬀective disorder and
the genetic relationship to unipolar depression,” Archives of
General Psychiatry, vol. 60, no. 5, pp. 497–502, 2003.
[59] J. P. Lin and S. J. Bale, “Parenteral transmission and D18S37
allele sharing in bipolar aﬀective disorder,” Genetic Epidemiol-
ogy, vol. 14, no. 6, pp. 665–668, 1997.
[60] E. S. Gershon, J. Hamovit, J. J. Guroﬀ, et al., “A family study
of schizoaﬀective, bipolar I, bipolar II, unipolar, and normal
control probands,” Archives of General Psychiatry, vol. 39, no.
10, pp. 1157–1167, 1982.
[61] M. M. Weissman, P. Wickramaratne, Y. Nomura, V. Warner,
D. Pilowsky, and H. Verdeli, “Oﬀspring of depressed parents:
20 years later,” American Journal of Psychiatry, vol. 163, no. 6,
pp. 1001–1008, 2006.
[62] P. J. Wickramaratne, V. Warner, and M. M. Weissman,
“Selecting early onset MDD probands for genetic studies:
results from a longitudinal high-risk study,” American Journal
of Medical Genetics. Neuropsychiatric Genetics, vol. 96, no. 1,
pp. 93–101, 2000.
[63] E. M. Cummings and P. T. Davies, “Maternal depression and
child development,” Journal of Child Psychology and Psychiatry
and Allied Disciplines, vol. 35, no. 1, pp. 73–112, 1994.
[64] S. H. Goodman and I. H. Gotlib, “Risk for psychopathology
in the children of depressed mothers: a developmental model
for understanding mechanisms of transmission,” Psychological
Review, vol. 106, no. 3, pp. 458–490, 1999.
[65] I. H. Gotlib and S. H. Goodman, “Children of parents with
depression,” in Developmental Issues in the Clinical Treatment
of Children and Adolescents, W. K. Silverman and T. H.
Ollendick, Eds., pp. 415–432, Allyn & Bacon, New York, NY,
USA, 1999.
[66] G. C. Williams, “Pleiotropy, natural selection, and the evolu-
tion of senescence,” Evolution, vol. 11, pp. 398–411, 1957.
[67] D. J. Pilowsky, P. Wickramaratne, Y. Nomura, and M. M.
Weissman, “Family discord, parental depression, and psy-
chopathology in oﬀspring: 20-year follow-up,” Journal of the
American Academy of Child & Adolescent Psychiatry, vol. 45,
no. 4, pp. 452–460, 2006.
[68] G. Downey and J. C. Coyne, “Children of depressed parents:
an integrative review,” Psychological Bulletin, vol. 108, pp. 50–
76, 1990.
[69] R. Lieb, B. Isensee, M. Hoﬂer, H. Pﬁster, and H.-U. Wittchen,
“Parental major depression and the risk of depression and
othermentaldisordersinoﬀspring:aprospective-longitudinal
community study,” Archives of General Psychiatry, vol. 59, no.
4, pp. 365–374, 2002.
[70] C. Peisah, H. Brodaty, G. Luscombe, and K. J. Anstey,
“Children of a cohort of depressed patients 25 years later: psy-
chopathologyandrelationships,”Journal of AﬀectiveDisorders,
vol. 82, no. 3, pp. 385–394, 2004.
[71] P. J. Wickramaratne and M. M. Weissman, “Onset of
psychopathology in oﬀspring by developmental phase and
parentaldepression,” JournaloftheAmericanAcademyofChild
& Adolescent Psychiatry, vol. 37, no. 9, pp. 933–942, 1998.
[72] M. M. Weissman, P. Wickramaratne, Y. Nomura, et al.,
“Families at high and low risk for depression: a 3-generation
study,” Archives of General Psychiatry, vol. 62, no. 1, pp. 29–36,
2005.
[73] P. Gorwood, “Generalized anxiety disorder and major depres-
sive disorder comorbidity: an example of genetic pleiotropy?”
European Psychiatry, vol. 19, no. 1, pp. 27–33, 2004.
[74] U.Rao,C.Hammen,L.R.Ortiz,L.-A.Chen,andR.E.Poland,
“Eﬀects of early and recent adverse experiences on adrenal
response to psychosocial stress in depressed adolescents,”
Biological Psychiatry, vol. 64, no. 6, pp. 521–526, 2008.
[75] I. C. G. Weaver, N. Cervoni, F. A. Champagne, et al.,
“Epigenetic programming by maternal behavior,” Nature
Neuroscience, vol. 7, no. 8, pp. 847–854, 2004.
[76] M. J. Dougher and L. Hackbert, “A behavior-analytic account
of depression and a case report using acceptance-based
procedures,” Behavior Analyst, vol. 17, pp. 321–334, 1994.
[77] C. B. Ferster, “A functional anlysis of depression.,” The
American psychologist, vol. 28, no. 10, pp. 857–870, 1973.
[78] J. W. Kanter, A. M. Busch, C. E. Weeks, and S. J. Landes,
“Thenatureofclinicaldepression:symptoms,syndromes,and
behavior analysis,” Behavior Analyst, vol. 31, no. 1, pp. 1–21,
2008.Depression Research and Treatment 7
[79] C.Darwin,“Recollectionsofthedevelopmentofmymindand
character,” in Autobiographies, 1876, C. Darwin, Ed., Penguin,
London, UK, 2002.
[80] M. C. Keller and R. M. Nesse, “Is low mood an adaptation?
Evidence for subtypes with symptoms that match precipi-
tants,” Journal of Aﬀective Disorders, vol. 86, no. 1, pp. 27–35,
2005.
[81] M. C. Keller and R. M. Nesse, “The evolutionary signiﬁcance
of depressive symptoms: diﬀerent adverse situations lead to
diﬀerent depressive symptom patterns,” Journal of Personality
and Social Psychology, vol. 91, no. 2, pp. 316–330, 2006.
[82] M. C. Keller, M. C. Neale, and K. S. Kendler, “Association of
diﬀerent adverse life events with distinct patterns of depressive
symptoms,” American Journal of Psychiatry, vol. 164, no. 10,
pp. 1521–1529, 2007.
[83] C. F. Sharpley, V. Bitsika, and D. R. H. Christie, “Understand-
ing the causes of depression among prostate cancer patients:
development of the eﬀects of prostate cancer on lifestyle
questionnaire,” Psycho-Oncology, vol. 18, no. 2, pp. 162–168,
2009.
[84] C. F. Sharpley, A. Tanti, J. M. Stone, and P. J. Lothian,
“The eﬀects of life events inventory,” Counselling Psychology
Quarterly, vol. 17, no. 1, pp. 45–52, 2004.
[85] J. W. Kanter, J. D. Cautilli, A. M. Busch, and D. E. Baruch,
“Toward a comprehensive functional analysis of depressive
behavior: ﬁve fundamental factors and a possible sixth and
seventh,” The Behavior Analyst Today, vol. 6, pp. 65–81, 2005.
[ 8 6 ]R .J .K o h l e n b e r g ,J .W .K a n t e r ,M .Y .B o l l i n g ,C .R .P a r k e r ,
andM.Tsai,“Enhancingcognitivetherapyfordepressionwith
functional analytic psychotherapy: treatment guidelines and
empirical ﬁndings,” Cognitive and Behavioral Practice, vol. 9,
no. 3, pp. 213–229, 2002.
[87] A.K.Moskowitz,““Scaredstiﬀ”:catatoniaasanevolutionary-
based fear response,” Psychological Review, vol. 111, no. 4, pp.
984–1002, 2004.